In weight management, GLP-1 receptor agonists (GLP-1 RAs) such as Semaglutide and Tirzepetide have emerged as transformative treatments
If you found this useful, follow me for more evidence-based protocols
Follow recommended dosage
NCL urges FDA and consumers to take action as GLP-1 shortage ends, but infodemic continues Media Contact: Lisa McDonald, Vice President of Communications, (202)-207-2829 May 22 Conclusion of Mass Compounded GLP-1s Should Bring Clarity but Confusion Reigns Washington, DC Despite the end of the GLP-1 shortage and May 22 FDA-issued deadline for companies to stop mass compounding of the products, the National Consumers League (NCL) is concerned that the epidemic of GLP-1 misinformation will continue to confuse consumers with fake products that can put their health at risk
A few postpone to accumulate additional evidence or to attempt more conservative interventions initially, such as aspirin, heparin, or lifestyle modifications
Trinh D, McDonald M
